Illumina Inc. (ILMN)
Health Care1 article
Price chart
Illumina Inc. (ILMN) overview
Illumina is the leading maker of DNA-sequencing systems. It is a member of the S&P 500 and is classified in the Health Care sector — pharmaceutical, biotech, device and managed-care companies.
Illumina Inc. trades on the NasdaqGS under the ticker symbol ILMN. As of the most recent market data, the stock was priced around $186.65, down 1.89% on the session, giving Illumina Inc. a market capitalization of roughly $28.24B.
Over the past 52 weeks, ILMN has traded between $88.00 and $196.66. Shares are valued at a trailing price-to-earnings (P/E) ratio of about 34.6, a common gauge of how richly the market prices the company's earnings.
Key statistics
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Why investors watch ILMN
As one of the larger companies in the Health Care sector, Illumina Inc. is closely followed by investors and often moves with broader trends across pharmaceutical, biotech, device and managed-care companies. Traders watch ILMN for earnings reports, analyst rating changes, and headlines that can shift sentiment — each of which is summarized on this page as it breaks.
Market Mood
Latest ILMN news
Illumina (ILMN) Form 144 Filed on June 5, Details Pending
Illumina (ILMN) filed Form 144 on June 5. This form typically indicates a proposed sale of shares by insiders. The filing could suggest potential stock sales in the market, which might influence investor sentiment. Details regarding the volume or price of the shares involved were not disclosed in the filing. Such filings are crucial as they provide insights into insider trading activity.
Read More: Illumina (ILMN) Form 144 Filed on June 5, Details PendingMore Health Care stocks
Frequently asked questions
Is Illumina Inc. in the S&P 500?
Yes. Illumina Inc. (ILMN) is a member of the S&P 500 index, classified in the Health Care sector.
What sector is ILMN in?
Illumina Inc. is classified in the Health Care sector of the S&P 500 — pharmaceutical, biotech, device and managed-care companies.
Where can I find the latest ILMN news?
This page collects recent Illumina Inc. (ILMN) news and market analysis, each article summarized by AI and tagged with bullish, bearish, or neutral sentiment.
What is Illumina Inc.'s stock price?
As of the most recent market data, Illumina Inc. (ILMN) traded at approximately $186.65. Prices move throughout the trading day, so this reflects the latest available quote rather than a live price.
What is Illumina Inc.'s market cap?
Illumina Inc. has a market capitalization of roughly $28.24B, based on its most recent share price and shares outstanding.
What is ILMN's P/E ratio?
ILMN trades at a trailing price-to-earnings ratio of about 34.6. The P/E ratio compares a company's share price to its earnings per share.